An analgesia circuit activated by cannabinoids
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although many anecdotal reports indicate that marijuana and its active constituent, delta-9-tetrahydrocannabinol (delta-9-THC), may reduce pain sensation, studies of humans have produced inconsistent results. In animal studies, the apparent pain-suppressing effects of delta-9-THC and other cannabinoid drugs are confounded by motor deficits. Here we show that a brainstem circuit that contributes to the pain-suppressing effects of morphine is also required for the analgesic effects of cannabinoids. Inactivation of the rostral ventromedial medulla (RVM) prevents the analgesia but not the motor deficits produced by systemically administered cannabinoids. Furthermore, cannabinoids produce analgesia by modulating RVM neuronal activity in a manner similar to, but pharmacologically dissociable from, that of morphine. We also show that endogenous cannabinoids tonically regulate pain thresholds in part through the modulation of RVM neuronal activity. These results show that analgesia produced by cannabinoids and opioids involves similar brainstem circuitry and that cannabinoids are indeed centrally acting analgesics with a new mechanism of action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“cannabinoids produce analgesia either in animal models of pain (both acute pain and tonic pain) or in clinical painful conditions (for reviews see: 161,221), and endogenous cannabinoids are tonically released to participate in the control of basal nociceptive threshold (137).”
From Paracetamol: New Vistas of an Old Drug (2006) · cites this paper as [137]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry
Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687
Self-citationSR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Cadas, H., di Tomaso, E., & Piomelli, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-04-01226.1997 · Cited by 396
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378
Research works printed but not linked: 1
- Buxbaum, D., Sanders-Bush, E. & Efron, D. Analgesic activity of tetrahydrocannabinol (THC) in the rat and mouse. Fed. Proc. 28, 735 (1969).
Cited by
Items 301–400 of 411
Contribution of the rostral ventromedial medulla to post-anxiety induced hyperalgesia
Cornélio, A. M., Nunes‐de‐Souza, R. L., & Morgan, M. M. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.037 · Cited by 9
“…of opioids and cannabinoids are known to be mediated in part by the nociceptive modulatory system that runs through the periaqueductal gray (PAG) and rostral ventromedial medulla (RVM) (Hohmann et al., 2005; Lane et al., 2005; Meng et al., 1998; Proudfit and Anderson, 1975; Yaksh et al., 1977).”
Neural basis for improgan antinociception
Heinricher, M. M., Martenson, M. E., Nalwalk, J. W., & Hough, L. B. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.042 · Cited by 8
“Focal application of μ-opioid and cannabinoid agonists in the RVM has a differential effect on the firing of these two classes, causing OFF-cells to become continuously active and suppressing ON-cell discharge (Heinricher et al., 1994; Meng et al., 1998; Meng and Johansen, 2004).”
BackgroundMascarenhas, D. C., Gomes, K. S., Sorregotti, T., & Nunes‐de‐Souza, R. L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00695 · Cited by 8
“…| Article 695 Morgan et al., 2014), glutamate (Yaksh and Noueihed, 1985; Palazzo et al., 2013; Wilson-Poe et al., 2013), serotonin (Eschalier et al., 1989; Baptista-de-Souza et al., 2014; de Freitas et al., 2014), and endocannabinoids (Meng et al., 1998; Suplita et al., 2005; Olango et al., 2012).”
BackgroundInfluentialFORMAN, L. J. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00103-5 · Cited by 8
Emerging analgesics in cancer pain management
Radbruch, L., & Elsner, F. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.1.151 · Cited by 8
“Another paper described central analgesic activity of cannabinoids mainly in the rostral ventromedial medulla involving similar brainstem circuitry, rather than opioids, but with a dissociable mechanism of action [82].”
BackgroundTwycross, R., & Bennett, M. (2008) · CRC Press eBooks · doi:10.1201/b13440-3 · Cited by 9
Challenges in the Federal Regulation of Pain Management Technologies
Noah, L. (2003) · The Journal of Law Medicine & Ethics · doi:10.1111/j.1748-720x.2003.tb00059.x · Cited by 8
Pearl‐Dowler, L., Posa, L., López-Canul, M., Teggin, A., & Gobbi, G. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110805 · Cited by 8
Shimoji, K., & Kurokawa, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2933-7_3 · Cited by 10
Holdcroft, A., & Patel, P. (2001) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.1.1.92 · Cited by 7
Cell–cell communication by Endocannabinoids during Immune Surveillance of the Central Nervous System
Ullrich, O., Schneider‐Stock, R., & Zipp, F. (2006) · Springer eBooks · doi:10.1007/400_015 · Cited by 7
ten Barge, J. A., van den Bosch, G. E., Slater, R., van den Hoogen, N. J., Reiss, I. K. M., & Simons, S. H. P. (2025) · Pediatric Drugs · doi:10.1007/s40272-024-00676-0 · Cited by 8
Orden, C., Santos, M., Ceprián, M., & Tendillo, F. J. (2020) · Veterinary Anaesthesia and Analgesia · doi:10.1016/j.vaa.2020.04.017 · Cited by 6
Is there a role for marijuana in medical practice?
Ware, M. A., Mg, K., & Srivastava, A. (2006) · PubMed Central · Cited by 6
Clarke, R. W., Harris, J. E., Jenkins, S., & Witton, S. K. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00179-9 · Cited by 8
The latest buzz on medicinal marijuana: A legal and medical perspective
Steinborn, J. J., Chinn, A. K., & Carter, G. T. (2001) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910101800502 · Cited by 6
Corli, G., Tirri, M., Bassi, M., Bernardi, T., Boccuto, F., Borsari, M., Zauli, G., Bilel, S., & Marti, M. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176486 · Cited by 5
Yun, C., Haleem, M. S., Jeong, S., Oyer, M. A., Driscoll, J. A., Chang, K. Y., Yun, J., Paul, J. T., Lubbe, R., Stock, S. R., et al. (2021) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.00573 · Cited by 6
Gonçalves, W. A., Ferreira, R. C. M., Rezende, B. M., Mahecha, G. A. B., Gualdron, M., de Macedo, F. H. P., Duarte, I. D. G., Perez, A. C., Machado, F. S., Cruz, J. S., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174089 · Cited by 7
ZHANG, Z.-Y., ZHONG, W.-X., ZHANG, K.-L., & Li, M. (2022) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2022.09.003 · Cited by 6
Lazarini-Lopes, W., Silva-Cardoso, G. K., de Oliveira, J. A. C., Passos, L. A. C., Salgado, A. R., Demolin, D. M. R., Leite‐Panissi, C. R. A., Garcia‐Cairasco, N., & Coimbra, N. C. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109160 · Cited by 5
Nocheva, H., Stoynev, N., Vodenicharov, V., Krastev, D. S., Krаstev, N., & Mileva, M. M. (2024) · Biomedicines · doi:10.3390/biomedicines12010235 · Cited by 5
“At the supraspinal level, cannabinoids have been proved to exert analgesic action in the periaqueductal gray [65,66], the thalamus [67], the rostral ventromedial medulla [68,69], and the amygdala [32,70].”
BackgroundAggarwal, S. K., Pangarkar, S. S., Carter, G. T., Tribuzio, B. A., Miedema, M. L., & Kennedy, D. J. “. J. ”. (2014) · PM&R · doi:10.1016/j.pmrj.2014.03.006 · Cited by 5
Opioid System Involvement in Cannabinoid Tolerance and Dependence
Maldonado, R. J. (1882) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_12 · Cited by 5
Pain management and weaning from narcotics and sedatives
Ganea, G. R., & Bogue, C. W. (1999) · Current Opinion in Pediatrics · doi:10.1097/00008480-199906000-00006 · Cited by 5
Liu, Q., He, W., Li, M., Li, Z., & Wu, C. (2025) · Journal of Pain Research · doi:10.2147/jpr.s548026 · Cited by 4
“21 This observation is consistent with prior reports of CB1-mediated analgesia in spinal and supraspinal circuits.”
Reduction of dependence to cannabinoids by GLT-1 activating property of the beta-lactam antibiotic
Ulugöl, A. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.040 · Cited by 4
“Cannabinoids and opioids activate a similar descending pain modulatory circuit; both increase off-cell activity and inhibit on-cell activity in the RVM [21].”
BackgroundHow cannabis works in the brain
Iversen, L. L. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511706080.002 · Cited by 11
Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2001) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.5.3.349 · Cited by 4
“In fact, an earlier investigation had suggested that endocannabinoids may play a part in down-modulating pain perception via CB1 receptors in another nucleus of the medulla/brainstem, the rostral ventromedial medulla, through the same neural circuit known to participate in the pain-suppressing effects of morphine (Fig…”
BackgroundMarijuana: Still a “Signal of Misunderstanding”
Ungerleider, J. T. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.09253.x · Cited by 4
Conrad, S. E., Davis, D., Vilcek, N., Thompson, J. B., Guarino, S., Papini, S., & Papini, M. R. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173320 · Cited by 3
Song, T., Ma, X., Ma, P., Gu, K., Zhao, J., Yang, Y., Jiang, B., Li, Y., & Wang, C. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24124 · Cited by 3
“Several studies have demonstrated that cannabinoid receptor agonists produce analgesia when microinjected into the RVM (Martin et al., 1998; Meng et al., 1998).”
BackgroundCarl, E., Mason, J. E., Smits, J. A. J., & Asmundson, G. J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00074-1 · Cited by 3
Endocannabinoid Degradation and Human Fertility
Bari, M., Battista, N., Cartoni, A., D’Arcangelo, G., & Maccarrone, M. (2002) · Journal of Cannabis Therapeutics · doi:10.1300/j175v02n03_03 · Cited by 3
“1998), which mimic some of the psychotropic, hypnotic and analgesic effects of cannabinoids (Calignano et al. 1998; Meng et al. 1998).”
BackgroundChronic Pain: Physiologic, Diagnostic, and Management Considerations
Hainline, B. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0334-6.50023-6 · Cited by 3
Le système de signalisation endocannabinoïde: structure, fonction, pharmacologie
Calvino, B. (2021) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2021.03.001 · Cited by 10
Lee, H. (2013) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2013.64.3.257 · Cited by 2
“Thus, possible interactions between opioids and cannabinoids have been suggested, and they have been investigated at receptorligand interaction and intracellular signal transduction level [5,6].”
BackgroundNeuropathic Pain: Mind-body Considerations
Hainline, B. W. (2010) · Neurologic Clinics · doi:10.1016/j.ncl.2010.10.007 · Cited by 2
Cannabis and Cannabinoids (PDQ
Integrative, P. (2011) · Cited by 2
Ita, M., & Kelly, J. P. (2019) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2019.29 · Cited by 3
“Among other supra-spinal structures and brain nuclei, the rostral ventral medulla, and the PAG matter, both constituent parts of the descending pain pathway have been shown to be significantly implicated in cannabinoid-induced antinociception (Martin et al. 1998; Meng et al. 1998; Walker et al. 2002; Lichtman et al. 1…”
BackgroundDaniel, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_40 · Cited by 2
Endocannabinoid Mechanisms of Pain Modulation
Hohmann, A. G., & Suplita, R. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-76678-2_44 · Cited by 4
Cannabis in Multiple Sclerosis: Women's Health Concerns
Petro, D. J. (2002) · Journal of Cannabis Therapeutics · doi:10.1300/j175v02n03_12 · Cited by 2
“In support of action at the level of the deep brain stem is the benefit seen with cannabis in intractable hiccups (Gilson and Busalacchi 1998) and evidence supporting cannabinoid analgesic actions mediated in the rostral ventromedial medulla (Meng et al. 1998).”
BackgroundEndogenous cannabinoids − a local message in and between the nervous and immune system
Ullrich, O., & Schneider‐Stock, R. (2005) · Signal Transduction · doi:10.1002/sita.200400043 · Cited by 2
Guest Editorial: Medical Marijuana, 1999: What in the World is Going on?
Ungerleider, J. T. (1999) · Substance Abuse · doi:10.1080/08897079909511395 · Cited by 2
Chronic inflammatory pain and chronic THC vapor inhalation alter midbrain neuronal activity
Kelley, L. K., Gilpin, N. W., & Middleton, J. W. (2025) · Journal of Neurophysiology · doi:10.1152/jn.00456.2024 · Cited by 1
Wang, L.-H., Han, Y., Zhou, W., Li, Q., Meng, Y., Liu, Y., & Sun, Y.-G. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.021 · Cited by 2
Involvement of Serotonergic System in Cannabinoid Analgesia
Dogrul, A. B., Seyrek, M., Yalçın, B., & Ulugöl, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7940-6_13 · Cited by 1
“The crucial role of descending pathways in systemic cannabinoid analgesia is also supported by the observation that inactivation of RVM by microinjection of GABA-A receptor agonist, muscimol, into it, totally prevents systemic WIN 55,212-2-induced analgesic effect in the tail-flick test (Meng et al. 1998).”
BackgroundCannabinoid Receptor Mediated Analgesia: Novel Targets for Chronic Pain States
Chapman, V., Kendall, D. A., & Sagar, D. R. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0226-9_15 · Cited by 2
The Uses of Cannabinoids in Medicine and Their Spectroscopic Applications
Er, A., & Çelik, S. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch010 · Cited by 1
Calvino, B. (2007) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/s1624-5687(07)91882-x · Cited by 1
Ram, S., & Clark, G. T. (2012) · doi:10.1002/9781118704851.ch13 · Cited by 1
Olango, W. M. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17506 · Cited by 2
Recent advances in pain management in palliative care
Linklater, G. T., & Leng, M. E. F. (2001) · Current Anaesthesia and Critical Care · doi:10.1054/cacc.2001.0360 · Cited by 1
Neuromodulatory Actions of Endocannabinoids in Pain and Sedation
PETROCELLIS, L. D., Bisogno, T., & Marzo, V. D. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9192-8_19 · Cited by 1
Local Neuroimmune Interactions in Visceral Hyperalgesia Bradykinin, Neurotrophins, and Cannabinoids
Rice, A. S. C. (2003) · CRC Press eBooks · doi:10.1201/9780203911259-12 · Cited by 1
Le regard des sciences sociales
Moigne, P. L., & Velpry, L. (2006) · HAL · Cited by 1
Morgan, A., Adank, D. N., Johnson, K., Blunt, E., & Patel, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480609 · Cited by 1
(2018) · Elsevier eBooks · doi:10.1016/b978-3-437-23672-3.00005-6 · Cited by 1
Effects of cannabidiol and cannabis extracts in models of convulsion and excitotoxicity
Utan, A. (2008) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/824
da Silva, J. A. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2011.tde-14082013-123119
Marijuana: Pharmacology and Interaction with the Endocannabinoid System
Wiley, J. L., & Martin, B. R. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn040
Brust, J. C. M. (2007) · Elsevier eBooks · doi:10.1016/b978-2-84299-712-0.50007-3
Neuronal Pathways for Pain Processing
Pasternak, G. W., & Zhang, Y. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn042
Marijuana as Medicine: Does It Have a Future?
Ware, M. A. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.6
The endocannabinoid signalling system: Implications for anaesthesia and the pain clinic
Dougalis, A., & Lees, G. (2005) · Current Anaesthesia and Critical Care · doi:10.1016/j.cacc.2005.03.004
“In parallel with this, endocannabinoids can lead to pain suppression in mammals and the hypothesis that they can act as endogenous painkillers has been tested successfully, implying that the endogenous system tonically regulates nociception.(84,85,95) Both pain and epilepsy are directly important in clinical anaesthet…”
BackgroundCannabis and the U.S. Controlled Substances Act
Gettman, J. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n01_09
“1998), and activation of a brainstem circuit also involved in opioid analgesia (Meng et al. 1998; Martin, W.J. et al. 1998).”
BackgroundThe Treatment of Neuropathic Pain with Cannabinoid Based Nanotechnology
Linsell, O. (2013) · Otago University Research Archive (University of Otago) · Cited by 1
Ultra-Low Dose Antagonist Effects on Cannabinoids and Opioids in Models of Pain: Is Less More?
Paquette, J. J. (2007) · QSpace (Queen's University Library)
Neurobiological mechanisms in pain control
Morinan, A. (2000) · Nursing and Residential Care · doi:10.12968/nrec.2000.2.6.7741
Toniolo, E. F. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2015.tde-09122015-064117
Lindberg, A. E. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Vanilloïdes, cannabinoïdes et nociception: aspects anatomiques
Conrath, M., Fischer, J., Salio, C., Franzoni, M. F., & Doly, S. (2001) · Douleur et Analgésie · doi:10.1007/bf03012690
The cannabinoid system and its role in nociception
Beltramo, M. (2016) · Wiley eBooks · doi:10.1002/9781118455968.ch6
PRECLINICAL STUDY OF ACUTE OROFACIAL MUSCULAR PAIN IN ANIMAL AND HUMAN MODELS
Carlos, R. J. (2012)
Chemical Communication Between Cells
Metzler, D. E., Metzler, C. M., & Sauke, D. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012492543-4/50033-7
Hudspith, M. J., & Munglani, R. (2003) · CRC Press eBooks · doi:10.1201/9780203911259.ch2
Descending mechanisms of cannabinoid stress analgesia
Suplita, R. L. (2003)
Dias, L. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-19072016-171535
Uso terapéutico de cannabinoides bajo prescripción médica
Villalobos, Z. A., & Flores-Sandí, G. (2009) · Acta Médica Costarricense · doi:10.51481/amc.v49i2.308
Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors
Karlsson, J. (2018) · DiVA (Digitala Vetenskapliga Arkivet)
Applied physiology: neuropathic pain
Wallace, V. C. J., & Rice, A. S. C. (2008) · CRC Press eBooks · doi:10.1201/b13472-1
“CB1 receptors are densely expressed in the PAG, and microinjection of CB1 agonists into the PAG or RVM produces antinociception.(190) CB1 receptors are also known to be expressed on rostrocaudally directed fibers in the dorsolateral funiculus, a major tract for descending control systems.”
BackgroundRice, A. S. C. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50034-4
Brust, J. C. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7313-6.50011-8
Challenges in the Federal Regulation of Pain Management TechnologiesPreprint
Noah, L. (2002) · SSRN Electronic Journal · doi:10.2139/ssrn.326584
Classification, Mechanism, Biochemistry, and Genetics of Headache
Ahn, A. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800901-7.00002-1 · Cited by 1
Role of Heteromeric GPCR Interactions in Pain/Analgesia
Smith, A. P., & Lee, N. M. (2005) · Contemporary clinical neuroscience · doi:10.1007/978-1-59259-919-6_16
Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence
MacCallum, C. A., de Freitas, L., Eadie, L., & Narouze, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_27
Medical Cannabis in Chronic Pain Management – Where Are We Now?
Haider, S., & Liew, W. (2021) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_1_21 · Cited by 1
Kelley, L. K., Lightfoot, S. H. M., Hill, M. N., Gilpin, N. W., & Middleton, J. W. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.23.461562
“agonists into the ventricles, the PAG and the RVM all produce analgesia in naïve male rats (Lichtman et al., 1996; Meng et al., 1998).”
BackgroundMecanismos de modulación del dolor del sistema nervioso central
Fields, H. L., Basbaum, A. I., & Heinricher, M. M. (2007) · Elsevier eBooks · doi:10.1016/b978-84-8174-949-6.50007-1 · Cited by 2
Self-citationEffets comportementaux des cannabinoïdes Données animales
Thiébot, M.-H., & Chaperon, F. (2001) · Douleur et Analgésie · doi:10.1007/bf03012691
Cannabis : l’antidouleur du futur ?
Calvino, B. (2021) · Cerveau & Psycho · doi:10.3917/cerpsy.128.0032
Cannabis : l’antidouleur du futur ?
Calvino, B. (2021) · Pour la Science · doi:10.3917/pls.519.0042
Pertwee, R. G. (2003) · CRC Press eBooks · doi:10.1201/9780203911259.ch56
Rice, A. S. C. (2006) · Elsevier eBooks · doi:10.1016/b0-443-07287-6/50039-4
Calvino, B. (2022) · Cerveau & Psycho · doi:10.3917/cerpsy.140.0048
Hainline, B. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0721-2.00023-4
Metadata
- Authors
- Meng, I. D., Manning, B. H., Martin, W. J., & Fields, H. L.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Meng, Ian D.
- Venue
- Nature
- Published
- 1998-09
- Volume
- 395
- Issue
- 6700
- Pages
- 381-383
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1645449597
- Cited by
- 411
- References
- 30
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 18 · 2020: 13 · 2019: 11 · 2018: 5 · 2017: 11 · 2016: 12 · 2015: 10 · 2014: 13 · 2013: 12 · 2012: 15
- FWCI
- 17.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid analgesia, delta-9-tetrahydrocannabinol, rostral ventromedial medulla, morphine analgesia, endocannabinoids, motor impairment, opioid analgesia
- MeSH terms
- Rimonabant, Analgesia, Animals, Cannabinoids, Male, Medulla Oblongata, Morphine, Morpholines, Motor Activity, Muscimol, Naphthalenes, Neural Pathways, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Rats, Sprague-Dawley, Analgesics, Non-Narcotic, GABA Agonists, Receptors, Cannabinoid, Benzoxazines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.